Nevro CorpNYSE:NVRO
- LAST PRICE9.5300
- TODAY'S CHANGE (%)-0.2800 (-2.8542%)
- Bid / Lots9.5200/ 2
- Ask / Lots9.5400/ 4
- Open / Previous Close9.7100 / 9.8100
- Day Range
- 52 Week Range
- Volume155,132
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NVRO |
|---|---|---|
| 09:32 ET | 7103 | 9.71 |
| 09:34 ET | 939 | 9.695 |
| 09:38 ET | 2638 | 9.47 |
| 09:39 ET | 2754 | 9.51 |
| 09:43 ET | 100 | 9.55 |
| 09:45 ET | 730 | 9.53 |
| 09:48 ET | 1943 | 9.56 |
| 09:50 ET | 631 | 9.585 |
| 09:52 ET | 800 | 9.56 |
| 09:54 ET | 100 | 9.565 |
| 09:56 ET | 100 | 9.565 |
| 10:01 ET | 3583 | 9.54 |
| 10:03 ET | 1005 | 9.55 |
| 10:06 ET | 1738 | 9.56 |
| 10:08 ET | 886 | 9.555 |
| 10:10 ET | 1355 | 9.55 |
| 10:12 ET | 14624 | 9.42 |
| 10:14 ET | 3361 | 9.45 |
| 10:15 ET | 600 | 9.46 |
| 10:17 ET | 400 | 9.46 |
| 10:19 ET | 1653 | 9.48 |
| 10:21 ET | 653 | 9.46 |
| 10:24 ET | 8380 | 9.46 |
| 10:26 ET | 5548 | 9.45 |
| 10:28 ET | 2415 | 9.42 |
| 10:30 ET | 6036 | 9.5 |
| 10:32 ET | 1199 | 9.495 |
| 10:33 ET | 1220 | 9.52 |
| 10:37 ET | 100 | 9.52 |
| 10:39 ET | 1399 | 9.57 |
| 10:42 ET | 2450 | 9.555 |
| 10:44 ET | 200 | 9.58 |
| 10:46 ET | 600 | 9.565 |
| 10:48 ET | 364 | 9.565 |
| 10:51 ET | 385 | 9.545 |
| 10:53 ET | 200 | 9.5299 |
| 10:55 ET | 100 | 9.5 |
| 11:00 ET | 318 | 9.46 |
| 11:02 ET | 200 | 9.45 |
| 11:06 ET | 350 | 9.4775 |
| 11:08 ET | 150 | 9.47 |
| 11:09 ET | 2751 | 9.485 |
| 11:11 ET | 200 | 9.485 |
| 11:13 ET | 900 | 9.485 |
| 11:15 ET | 200 | 9.485 |
| 11:18 ET | 300 | 9.5 |
| 11:20 ET | 300 | 9.485 |
| 11:22 ET | 500 | 9.49 |
| 11:24 ET | 3545 | 9.515 |
| 11:26 ET | 1605 | 9.52 |
| 11:27 ET | 1451 | 9.54 |
| 11:29 ET | 400 | 9.55 |
| 11:31 ET | 723 | 9.6 |
| 11:33 ET | 100 | 9.58 |
| 11:38 ET | 481 | 9.55 |
| 11:42 ET | 1923 | 9.51 |
| 11:44 ET | 200 | 9.505 |
| 11:45 ET | 100 | 9.495 |
| 11:47 ET | 800 | 9.5 |
| 11:49 ET | 722 | 9.51 |
| 11:54 ET | 100 | 9.51 |
| 11:56 ET | 1314 | 9.53 |
| 12:05 ET | 7574 | 9.61 |
| 12:09 ET | 100 | 9.62 |
| 12:12 ET | 600 | 9.61 |
| 12:14 ET | 1579 | 9.6 |
| 12:18 ET | 2951 | 9.5384 |
| 12:20 ET | 100 | 9.52 |
| 12:21 ET | 100 | 9.53 |
| 12:23 ET | 100 | 9.53 |
| 12:25 ET | 466 | 9.51 |
| 12:32 ET | 1100 | 9.535 |
| 12:34 ET | 550 | 9.53 |
| 12:36 ET | 3225 | 9.6 |
| 12:39 ET | 200 | 9.57 |
| 12:41 ET | 250 | 9.57 |
| 12:45 ET | 1518 | 9.54 |
| 12:48 ET | 1139 | 9.515 |
| 12:50 ET | 100 | 9.515 |
| 12:54 ET | 2124 | 9.51 |
| 12:56 ET | 1195 | 9.54 |
| 12:57 ET | 100 | 9.55 |
| 12:59 ET | 200 | 9.535 |
| 01:01 ET | 995 | 9.53 |
Yesterday
DJ Nevro Cut to Sell From Neutral by Citigroup, from 9:01AM ET on Wednesday May 22, 2024 by Dow Jones
9:01AM ET on Wednesday May 22, 2024 by Dow Jones
May 9, 2024
Nevro to Present at BofA Securities 2024 Healthcare Conference, from 4:05PM ET on Thursday May 09, 2024 by Dow Jones
4:05PM ET on Thursday May 09, 2024 by Dow Jones
May 8, 2024
DJ Nevro Is Maintained at Hold by Canaccord Genuity, from 1:00PM ET on Wednesday May 08, 2024 by Dow Jones
1:00PM ET on Wednesday May 08, 2024 by Dow JonesDJ Nevro Is Maintained at Equal-Weight by Wells Fargo, from 10:52AM ET on Wednesday May 08, 2024 by Dow Jones
10:52AM ET on Wednesday May 08, 2024 by Dow JonesDJ Nevro Is Maintained at Underweight by Piper Sandler, from 8:28AM ET on Wednesday May 08, 2024 by Dow Jones
8:28AM ET on Wednesday May 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nevro Corp | 360.3M | -4.2x | --- |
OraSure Technologies Inc | 373.5M | 16.1x | +75.98% |
ZimVie Inc | 475.4M | -8.8x | --- |
AngioDynamics Inc | 253.1M | -1.3x | --- |
Tactile Systems Technology Inc | 307.0M | 10.7x | +29.16% |
Bioventus Inc | 501.6M | -18.3x | --- |
Company Information
Nevro Corp. is a global medical device company. The Company is focused on delivering solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. Its comprehensive HFX spinal cord stimulation 3 (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy. It has developed and commercialized its HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain, with the Senza HFX iQ platform. Its HFX solution delivers a range of waveforms, including its paresthesia-free 10 kHz Therapy. Its 10 kHz Therapy is designed to deliver neuromodulation solutions for treating chronic pain. Its products include Senza II SCS System, Senza Omnia SCS System, Senza Omnia upgrade, Omnia Powered by HFX Connect, Senza HFX iQ System, and Surpass Surgical Lead.
Contact Information
- Headquarters
- 1800 Bridge ParkwayREDWOOD CITY, CA, United States 94065
- Phone
- 650-251-0005
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- D. Keith Grossman
- President, Chief Executive Officer
- Kevin Thornal
- Chief Financial Officer, Senior Vice President
- Roderick Macleod
- Chief Operating Officer
- Christopher Christoforou
- Senior Vice President, Chief Medical Officer
- David Caraway
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $360.3M |
|---|---|
Revenue (TTM) | $430.7M |
Shares Outstanding | 36.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.95 |
EPS | $-2.28 |
Book Value | $8.06 |
P/E Ratio | -4.2x |
Price/Sales (TTM) | 0.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -22.03% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
